Skip to main content

Hydroxyamphetamine / tropicamide ophthalmic Pregnancy and Breastfeeding Warnings

Hydroxyamphetamine / tropicamide ophthalmic is also known as: Paremyd

Hydroxyamphetamine / tropicamide ophthalmic Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: C

Animal studies have not been reported. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Hydroxyamphetamine / tropicamide ophthalmic Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Paremyd (hydroxyamphetamine-tropicamide ophthalmic)." Akorn Inc (2013):

References for breastfeeding information

  1. "Product Information. Paremyd (hydroxyamphetamine-tropicamide ophthalmic)." Akorn Inc (2013):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.